Treatment success rate for patients treated for MDR-TB in United Arab Emirates
United Arab Emirates: Treatment success rate for patients treated for MDR-TB was 100.0% in 2022. ◆ Volatile
Treatment success rate for patients treated for MDR-TB in United Arab Emirates, 2007–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in United Arab Emirates is 100.0%, measured in 2022. That is the highest value across all 9 years on record.
That represents a change of up 100.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in United Arab Emirates peaked at 100.0% in 2007 and was at its lowest, 0.0%, in 2014.
United Arab Emirates ranks 1st of 163 countries on this measure, in the top 10%.
Treatment success rate for patients treated for MDR-TB in United Arab Emirates, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 100.0% | — |
| 2009 | 100.0% | +0.0% |
| 2011 | 100.0% | +0.0% |
| 2012 | 50.0% | -50.0% |
| 2014 | 0.0% | -100.0% |
| 2016 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2022 | 100.0% | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 100.0% | 2 |
| 2010s | 25.0% | 0.0% | 100.0% | 6 |
| 2020s | 100.0% | 100.0% | 100.0% | 1 |
Countries ranked near United Arab Emirates
- 1 New Zealand 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Jordan 100.0% compare
- 1 Serbia 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Belize 100.0% compare
- 1 Macau, China 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Kiribati 100.0% compare
- 1 Cape Verde 100.0% compare
- 1 Puerto Rico 100.0% compare
- 1 Costa Rica 100.0% compare
- 1 Micronesia, Federated States of 100.0% compare
More health data for United Arab Emirates
- Un projection of annual infant deaths, annual growth rate -0.3472 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 2.97 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 308.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 287 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 6.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.0264 units per person (2025)
- Population ages 00-04, male, annual growth rate 3.35 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2024)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in United Arab Emirates?
- Treatment success rate for patients treated for mdr-tb in United Arab Emirates was 100.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in United Arab Emirates?
- The highest recorded value was 100.0% in 2007.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in United Arab Emirates?
- The lowest recorded value was 0.0% in 2014.
- How does United Arab Emirates rank for treatment success rate for patients treated for mdr-tb?
- United Arab Emirates ranks 1st out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in United Arab Emirates?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is volatile.
- Where does this United Arab Emirates data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).